January 10, 2002





Securities and Exchange Commission
Washington DC  20549

Dear Sir or Madam:

On behalf of Patrick Waddy, who is an Officer of Immucor,  Inc. (the "Company"),
we are transmitting  the Statement of Changes in Beneficial  Ownership on Form 4
with respect to the Company's Common Stock.

Sincerely,

/s/ Edward L. Gallup

Edward L. Gallup
President



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 4
                  Statement of Changes in Beneficial Ownership

                Filed pursuant to Section 16(a) of the Securities
            Exchange Act of 1934, Section 17(a) of the Public Utility
         Holding Company Act of 1935 or Section 30(f) of the Investment
                               Company Act of 1940


___  Check  this  box if no  longer  subject  to  Section  16.  Form 4 or Form 5
     obligations may continue. See Instructions 1(b).

1.   Name and Address of Reporting Person

         Patrick Waddy
         C/o Dominion Biologicals
         5 Isnor Drive
         Dartmouth, NS B3B 1M1 Canada

2.   Issuer Name and Ticker or Trading Symbol

         Immucor, Inc./BLUD

3.   IRS or Social Security Number of Reporting Person (Voluntary)

         NA

4.   Statement for Month/Year

         12/01

5.   If Amendment, Date of Original (Month/Year)

         NA

6.   Relationship of Reporting Person to Issuer (check all applicable)

                  Director
         X        Officer (give title below)
                  10% Owner
                              Other (specify below)

         President of Dominion Biologicals and European Finance Director





TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.       Title of Security   (Instr.3)

         NA

2.   Transaction Date (Month/Day/Year)

         NA

3.   Transaction Code (Instr. 8)

         NA

4.   Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

         Amount               (A) or (D)            Price

         NA

5.  Amount of Securities       6.  Ownership Form:     7.  Nature of Indirect
    Beneficially Owned at           Direct (D) or         Beneficial Ownership
    End of Month                    Indirect (I)              (Instr. 4)
    (Instr. 3 and 4)                (Instr. 4)

    31,000 (as previously reported)     D                       N/A


TABLEII - Derivative  Securities  Acquired,  Disposed of, or Beneficially  Owned
     (e.g., puts, calls, warrants, options, convertible securities)

1.   Title of Derivative Security (Instr. 3)

(i)      Stock Option - Right to buy
(ii)     Warrant - Right to buy

2.   Conversion or Exercise Price of Derivative Security

(i)      $6.75
(ii)     $11.98

3.   Transaction Date (Month/Day/Year)

(i)      12/3/01
(ii)     12/11/96

4.   Transaction Code (Instr. 8)

(i)      T
(ii)     J

5.   Number of Derivative  Securities Acquired (A) or Disposed of (D) (Instr. 3,
     4 and 5)

         Options as previously reported     30,500
                  (A)                       (D)
         (i)      15,000                    NA
         (ii)     50,000                    NA

6.   Date Exercisable and Expiration Date (Month/Day/Year)

                  Date Exercisable          Expiration Date
         (i)      12/3/03                            12/3/11
         (ii)     12/11/96                  12/11/06

7.   Title and Amount of Underlying Securities (Instr. 3 and 4)

                  Title          Amount or Number of Shares
         (i)      12/3/03                15,000
         (ii)     12/11/96               50,000

8.   Price of Derivative Security (Instr. 5)

                  NA

9.   Number of Derivative  Securities  Beneficially Owned at End of Year (Instr.
     4)

         30,500   (as previously reported)
         65,000   derivative securities acquired
         --------
         95,500   Total owned at end of year

10.  Ownership Form of Derivative  Security:  Direct (D) or Indirect (I) (Instr.
     4)

         D

11.  Nature of Indirect Beneficial Ownership (Instr. 4)

         NA

Explanation of Responses:


(i)  Stock  options  are  exercisable  50% on  12/3/03,  and 25% on 12/3/04  and
     12/3/05.
(ii) Warrants issued in acquisition of Dominion Biologicals


/s/Patrick Waddy, by Steven C. Ramsey as Power of Attorney
----------------------------------------------------------
Signature of Reporting Person

1/10/02
Date